Atlas Trials

An Open-label Long-term Follow-up Study of SAT-3247 for Participants With Duchenne Muscular Dystrophy Including Those Who Participated in SAT-3247-CL-101

Clinical trial NCT06867107 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06867107
Sponsor
Satellos Bioscience, Inc.
Status
ENROLLING_BY_INVITATION
Phase
Phase 2
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy (DMD)
Start date
2025-08-20
Primary completion
2026-08-30
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.